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ABSTRACT: Background: Perﬂuorinated chemicals (PFCs) have been used widely in consumer products since the 1950s and are
currently found at detectable levels in the blood of humans and animals across the globe. In stark contrast to this widespread
exposure to PFCs, there is relatively little research on potential adverse health eﬀects of exposure to these chemicals. Objectives: We
performed this cross-sectional study to determine if speciﬁc blood PFC levels are associated with impaired response inhibition in
children. Methods: Blood levels of 11 PFCs were measured in children (N = 83) and 6 PFCs: perﬂuorooctane sulfonate (PFOS),
perﬂuorohexane sulfate (PFHxS), perﬂuorooctanoic acid (PFOA), perﬂuorononanoic acid (PFNA), perﬂuorooctanesulfonamide
(PFOSA), and perﬂuorodecanoic acid (PFDA)  were found at detectable levels in most children (87.5% or greater had detectable
levels). These levels were analyzed in relation to the diﬀerential reinforcement of low rates of responding (DRL) task. This task
rewards delays between responses (i.e., longer inter-response times; IRTs) and therefore constitutes a measure of response
inhibition. Results: Higher levels of blood PFOS, PFNA, PFDA, PFHxS, and PFOSA were associated with signiﬁcantly shorter IRTs
during the DRL task. The magnitude of these associations was such that IRTs during the task decreased by 2934% for every 1 SD
increase in the corresponding blood PFC. Conclusions: This study suggests an association between PFC exposure and children’s
impulsivity. Although intriguing, there is a need for further investigation and replication with a larger sample of children.

’ INTRODUCTION
Perﬂuoroalkyl acids constitute a general class of chemicals
that include a number of commonly used perﬂuorinated chemicals
(PFCs), including perﬂuorooctane sulfonate (PFOS), perﬂuorohexane sulfate (PFHxS), and perﬂuorooctanoic acid (PFOA). These
chemicals have been widely used in consumer and industrial products.
With the widespread use of these chemicals and a marked resistance
to metabolic or environmental degradation, detectable levels of PFCs
have now been documented in wildlife around the world1,2 as well as
in humans with3 and without4,5 occupational exposure. Despite a
widespread exposure to this class of chemicals, relatively little is
known about potential eﬀects to human health and behavior.
A number of studies have considered the potential eﬀects of
prenatal exposure to PFOA and PFOS on birth outcomes in
humans. PFOA (but not PFOS) was associated with signiﬁcantly
lower birth weight6 as well as smaller birth length and abdominal
circumference7 in the Danish National Birth Cohort. “Signiﬁcance”
refers to statistical signiﬁcance (not necessary clinical signiﬁcance)
here and throughout this manuscript. In contrast to these signiﬁcant
eﬀects, another study found that PFOS (but not PFOA) were negatively correlated with birth weight, and speciﬁcally in female infants.8
In addition, PFOA and PFOS were not signiﬁcantly associated with
birth weight but both PFOA and PFOS were signiﬁcantly associated
with lower ponderal index and head circumference.9 Finally, other
research has revealed no signiﬁcant association between birth outcomes and maternal PFC levels.10,11 Based on these inconsistencies,
additional research is necessary to determine if prenatal exposure to
r 2011 American Chemical Society

certain PFCs are indeed related to birth outcomes12 and, if so, to
which outcomes.
In addition to the study of birth outcomes, a number of studies
have considered potential neurobehavioral eﬀects of PFC exposure in humans. For example, potential neurobehavioral consequences of prenatal exposure to PFOA and PFOS were considered in
the Danish National Birth Cohort.13,14 In this cohort, PFOS was
associated with delayed gross motor development in the ﬁrst two
years of life14 but no other signiﬁcant associations with developmental milestones during the ﬁrst two years of life or children’s
subsequent behavioral or coordination problems at age 7 were found
in this cohort.13 Two studies have considered children’s serum
PFOA, PFOS, PFNA, and PFHxS in relation to parental reports of
ADHD diagnosis (with and without medication). First, a crosssectional analysis of data from the National Health and Nutrition
Examination Survey (NHANES) 19992000 and 20032004 for
children 1215 years of age (N = 571) found signiﬁcant adjusted
odds ratio (OR) for ADHD in association with a 1-μg/L increase in
serum PFOS (OR = 1.03; 95% CI: 1.011.05), PFOA (OR = 1.12;
95% CI: 1.011.23), and PFHxS (OR = 1.06; 95% CI: 1.021.11),
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but no signiﬁcantly increased odds of ADHD for children with higher
serum perﬂuorononanoic acid (PFNA15). Second, a cross-sectional
study was conducted with children 518 years of age (N = 10 546)
in the C8 Health Project (a study of community residents in Ohio
and West Virginia who lived or worked in areas with PFOAcontaminated water supplies16). In this study, the OR for ADD/
ADHD was signiﬁcantly lower with increasing PFOA (OR = 0.80;
95% CI: 0.670.95) but signiﬁcantly greater with increasing PFHxS
(OR = 1.33; 95% CI: 1.111.59), but no signiﬁcant association with
PFOS or PFNA. The reason for the inconsistency across these
studies is not yet understood.
A number of studies have also considered the potential
reproductive and developmental eﬀects of PFC exposure using
animal models. Initial studies were performed in the rat; however,
rats may not be the ideal species in which to study PFOA exposure
eﬀects given rapid elimination of PFOA in female rats.17 Increasing
prenatal exposure to PFOA in rats was associated with diminished
postnatal weight gain and postweaning survival.18 Similarly, prenatal
exposure to PFOS was associated with greater postnatal mortality
and, for those that survived, developmental delays.19,20 Subsequent
studies with lower prenatal doses of PFOS in rats revealed greater
motor activity and diminished capacity to habituate to the testing
environment in oﬀspring.21 However, prenatal exposure to PFHxS in
rats produced no signiﬁcant eﬀects on mating, fertility, birth outcomes, and development of oﬀspring.22 In studies of prenatal exposure to PFCs in mice, there was slightly diminished activity in
an open-ﬁeld test with increasing PFOS.23 Similarly, neonatal exposure to PFOS and PFOA was associated with diminished habituation to a novel environment and lack of activity (measured with
locomotion, rearing, and total activity;.24 Studies that have considered
combined maternal stress and prenatal exposure to PFOS have failed
to ﬁnd any consistent interactions; however, increasing PFOS was
associated with fetal toxicity,25 decreased corticosterone levels in
females,26 and some evidence of delayed neuromotor maturation.27
The biological mechanism for potential PFC-induced neurobehavioral problems has yet to be determined. Perhaps prenatal PFC
exposure aﬀects birth outcomes and, in turn, these birth outcomes
(e.g., birth weight) produce attentional problems.28 Alternatively,
PFCs might have direct eﬀects on the central nervous system.
Although PFC exposure does not appear to produce diﬀerential
accumulation in the brain,29 it is detectable in brain tissue following
oral exposure.30 Furthermore, although PFC levels in brain tissue are
much lower than corresponding levels in serum, these levels might
still be suﬃcient to aﬀect CNS functioning. For example, PFOS and
PFOA have been shown to aﬀect proteins in the brain that may aﬀect
neuronal growth and synaptogenesis.31 Additional evidence suggests
that exposure to PFOS is associated with an increase in norepinephrine concentrations in the paraventricular nucleus of the
hypothalamus,32 suggesting a possible pathway to nucleus accumbens activity33 and impulsivity.34 However, this particular neurobiological pathway has yet to be established in humans.
In the present study, we conducted a cross-sectional investigation of potential emotional and behavioral associations with blood
PFC levels in children. Children are an important population given
the potential for a child’s environmental context to set a trajectory for
signiﬁcant eﬀects in adolescence and adulthood (e.g., ref 35).
Speciﬁcally, we considered potential PFC eﬀects using a task shown
to be sensitive to environmental toxicant exposure, the diﬀerential
reinforcement of low rates of responding (DRL) task. The DRL task
is a well-established behavioral measure of impulsivity36 aﬀected by
exposure to a wide range of environmental toxicants.37 Therefore,
our study considers the hypothesis that increasing blood PFC levels
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will be associated with increasing impulsivity in children as measured
using the DRL task.

’ EXPERIMENTAL SECTION
Participants. Participants were recruited as part of an ongoing
study designed to address the effects of low level lead (Pb) exposure
on cardiovascular responses to acute stress.38 For that study (N =
100), we mailed invitations to homes in Oswego County, NY,
containing a child within our target age group (911) using a direct
mailing list. This recruitment method elicits participation from a
sample that closely resembles an eligible population and is costeffective.39 Further inclusion criteria included (1) reporting no use
on the day of testing of medication that might affect cardiovascular
functioning (e.g., Ritalin), and (2) having no significant developmental disorders that might affect task performance (a component of
our broader study). After acquiring funding for the present study, we
began drawing an additional 2 mL of whole blood necessary for the
analysis of PFC levels after having already completed blood draws
and testing for 12 children. In addition, we were unable to obtain
sufficient blood for the additional analysis of PFC levels for five
children. For these five children (100% female), their initial venipuncture site closed during the draw and it was our policy to not
attempt a second venipuncture if we had sufficient blood for the
measurement of nonessential metals, the primary focus of our
project. It is unclear why this occurred exclusively with female
participants. With the exception of gender, this resulted in a final
sample of 83 children (30 females, 53 males) that did not differ
significantly from our full sample (N = 100) on any dimensions
measured with our covariates (e.g., BMI, race, and family income;
p values >0.10). In addition, gender was not significantly associated
with the PFCs we measured (p-values > 0.20).
Measurement of Blood PFC Levels. Participants arrived at
the blood draw center and signed an assent form while a parent
signed a separate consent form approved by the Institutional Review
Board of SUNY Oswego. As part of a more extensive blood draw
protocol, a whole blood specimen (2-mL) was collected into a
Vacutainer tube for the analysis of PFC blood levels. Blood specimens were immediately placed on ice and within 2 h of the blood
draw the samples were transferred to 10 mL cryovials and frozen at
80 °C pending shipment to Wadsworth Center, Albany, NY.
Chemical Analysis. PFOS, PFHxS, perfluorobutanesulfonate
(PFBS), perfluorodecanesulfonate (PFDS), perfluorooctanesulfonamide (PFOSA), perfluoroheptanoic acid (PFHpA), PFOA,
PFNA, perfluorodecanoic acid (PFDA), perfluoroundecanoic acid
(PFUnDA), and perfluorododecanoic acid (PFDoDA) were analyzed in whole blood samples using an ion-pairing extraction
procedure and were determined by use of high-performance liquid
chromatography-electrospray tandem mass spectrometry (HPLCESI-MS/MS).40,41 Approximately 0.5 mL of blood sample, 5 ng of
internal standards (13C4PFOS, 13C4PFOA, 13C2PFNA, and
13
C2PFDA), 2 mL of 0.25 M sodium carbonate/sodium bicarbonate buffer and 1 mL of 0.8 M tetrabutyl ammonium hydrogen
sulfate solution (adjusted to pH 11), were added to a 15 mL
polypropylene tube for extraction. After thorough mixing, 5 mL of
methyl tert-butyl ether (MTBE) was added, and the mixture was
shaken for 40 min. The organic and aqueous layers were separated by
centrifugation at 3500 rpm for 3 min and an exact volume of MTBE
(4 mL) was removed from the solution. The aqueous mixture was
rinsed with 3 mL MTBE and separated twice; the rinses were
combined in a second polypropylene tube. The solvent was allowed
to evaporate gently under nitrogen stream before being reconstituted
8152
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in 0.5 mL of methanol. The sample was vortexed for 30 s and
transferred into an autosampler vial prior to instrumental analysis.
Analyte separation was performed using an Agilent1100 series
HPLC. Ten microliter of the extract was injected onto a 100 
2.1 mm (5 μm; Thermo Electron Corporation, Bellefonte, PA)
Betasil C18 column with 2 mM ammonium acetate/methanol as the
mobile phase starting at 10% methanol. At a ﬂow rate of 300 μL/min,
the gradient increased to 100% methanol at 10 min before reverting
to original conditions at 12 min. For quantitative determination, the
HPLC system was interfaced to an API 2000 triple-quadruple
tandem mass spectrometer (Applied Biosystems, Foster City, CA)
operated in the electrospray negative ionization mode. Instrumental
parameters were optimized to transmit the [M-K] ion before
fragmentation to one or more product ions. Declustering potential
and collision energies were optimized for each analyte and ranged
from 35 to 90 V and 10 to 35 eV, respectively. Data were acquired by
tandem mass spectrometry using multiple reaction monitoring
(MRM) at transitions, 499 > 99 for PFOS, 503 > 99 for 13C4
PFOS, 497.7 > 77.7 for PFOSA, 398.7 > 79.7 for PFHxS, 298.7 >
79.7 for PFBS, 599 > 99 for PFDS, 363 > 319 for PFHpA, 413 > 369
for PFOA, 417 > 372 for 13C4PFOA, 463 > 419 for PFNA, 465 >
420 for 13C2PFNA, 513 > 469 for PFDA, 515 > 470 for
13
C2PFDA, 563 > 519 for PFUnDA, and 613 > 169 for PFDoDA.
When possible, multiple daughter ions were monitored for conﬁrmation, but quantitation was based on a single product ion. In all
cases, the capillary was held at 4 kV and the desolvation temperature was kept at 400 °C.
Quality Assurance and Quality Control. 13C4PFOS,
13
C4PFOA (99% purity, Wellington Laboratories, Guelph,
ON, Canada), 13C2PFNA and 13C2PFDA (3 M Company,
St. Paul, MN) were spiked as internal standards into each blood
sample prior to the addition of reagents for extraction. PFC
concentrations were calculated by isotopic dilution method, and
further confirmed by matrix matched calibration standards. Recoveries of 13C4PFOS, 13C4PFOA, 13C2PFNA, and 13C2PFDA
were 98 ( 5%, 124 ( 7%, 109 ( 6%, and 141 ( 13%, respectively.
Matrix spike recoveries were tested by spiking native standards of all
11 target compounds into 12 randomly selected samples, at levels of
10 ng and 20 ng for each of the target compounds. All the matrix
spike samples were analyzed in duplicate. Recoveries of native
standards spiked in blood matrix were 96 ( 6%, 101 ( 6%, 114
( 7%, and 105 ( 5%, for PFOS, PFHxS, PFOA, and PFNA,
respectively. The average recoveries for other perfluorochemicals
ranged from 70% to 125%. The relative standard deviations (RSD)
of duplicate analyses were less than 5% for PFOS, PFHxS, PFBS,
PFDS, PFOA, PFNA, PFDA, PFHpA, and less than 10% for
PFOSA, PFUnDA, and PFDoDA. Milli-Q water (18 MΩ) was
analyzed through the entire procedure as a blank, for every batch of
20 samples. Procedure blanks were also spiked with native standards. The recoveries of native standards spiked in water blanks
were 96%, 85%, 108%, 109%, and 113% for PFOS, PFHxS, PFOA,
PFNA, and PFDA, respectively. Solvents and blood collection tubes
were checked for the presence of the perfluorochemicals analyzed in
this study. Concentrations in blanks are below limit of detection for
all eleven perfluorochemicals. The limit of quantitation (LOQ) was
determined based on the linear range of the calibration curve
prepared at a concentration range of 0.2100 ng/mL. Concentrations in samples which were at least 3-fold greater than the lowest
acceptable standard concentration were considered to be valid. A
curve point was deemed acceptable if (1) it was back-calculated to
be within 30% of the theoretical value when evaluated versus the 1/x
weighted curve, and (2) the peak area of the standard was at least 3
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times greater than that in the blank. Concentration/dilution factors
were included in the calculation of the LOQ. The LOQ for PFOS
and PFOA was 0.2 and 1.0 ng/mL, and for other perfluorochemicals, it ranged from 0.2 to 1.0 ng/mL. Three of the perfluorochemicals (PFBS, PFDS, and PFUnDA) had levels below the LOQ for all
samples and are therefore not discussed further. Two of the
perfluorochemicals (PFHpA and PFDoDA) had more than 50%
of the samples below the LOQ and therefore results from the
analysis of these two PFCs are not reported here (but are included in
our online Supporting Information (SI) Table S1). Total PFC
levels were computed by summing the remaining six PFCs, and
for those PFCs having some levels below the LOQ, 1/2 the value of
the LOQ for the particular PFC was used (cf., ref 42). For those 6
PFCs having levels above the LOQ in 50% of the children, separate
analyses were conducting for each PFC.
Procedure. All blood draws occurred on Friday and a laboratory session was scheduled for the following week. The laboratory
session commenced with the measurement of height and weight.
Unrelated to the present paper, all children underwent an initial
cardiovascular acute stress reactivity protocol for 1 h (see ref 38 for
details). These cardiovascular responses to acute stress were analyzed in relation to DRL performance (a 20 min task that followed
this cardiovascular stress testing) and PFC levels and are reported in
SI Table S2. The number of significant associations (5) was approximately what you would expect from chance and the analysis of 80
associations. In addition, the pattern of association (with early and
late DRL performance) does not coincide with PFC association
(with middle DRL performance).
Differential Reinforcement of Low Rates of Responding
(DRL) Task. As employed in a previous study that demonstrated
behavioral inhibition deficits as a function of toxicant exposure in
children,37 we adopted a relatively short (20 min) DRL task as an
assessment of learning rather than acquisition, which can take
hours37 or days.43 The present DRL task was presented using an
E-Prime (Psychology Software Tools, Inc.) program. Participants
were only told:
“You are now going to play a computer game in which you can
earn additional money. During this game, I will not be able to speak
to you. It is ﬁne if you speak to me while you are playing, but I can’t
answer any questions. I will tell you when the game starts, and when
it’s over. I can’t tell you the rules to this game—you will need to
ﬁgure that out on your own. All I can tell you is that pressing the
button at the correct time is all that is involved in this game. If played
correctly, you could win as much as $15.00!”
The task was then begun and participants earned $.25 for the
ﬁrst three responses and this was followed by a DRL20 schedule.
According to the DRL20 schedule, if the space bar was pressed
before the completion of 20 s, the time was reset to 20 s and no
money was earned. If a response (bar press) occurred 20 s or longer
following a prior response, $.25 was earned and the computer screen
showed the following message: “CORRECT! You have earned
another $.25”. The program sequentially recorded the inter-response time (IRT) of each bar press within a millisecond of
precision. IRTs represent the time between responses (i.e., bar
presses) and therefore rapid responding will be reﬂected by short
IRTs and delayed responding will be reﬂected by longer IRTs. The
IRTs were stored for subsequent analysis.
Potential Confounds. To strengthen our inferences regarding
the effects of children’s blood PFC levels, we considered a number
of potential confounds, including ages (child, mother, and father),
family income, parent’s education, parent’s occupational class, BMIs
(child, mother, and father), child’s gender, child’s race, family history
8153
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Table 1. Characteristics (Mean and SD or %) of Participants
(N = 83)
measure

mean (SD)/%

Table 2. PFC Content (ng/mL) in Blood Samples (Mean,
Standard Deviation, Median, Minimum, Maximum, % of
Samples with Levels Above LOQ) of Participants (N = 83)
mean SD median

minimum

maximum % above LOQ

child age (yrs)

10.13 (0.56)

mother’s age (yrs)
father’s age (yrs)

39.80 (5.85)
43.28 (9.34)

total PFC

21.6

14.0

19.1

5.29

91.9

PFOS

9.90

6.09

8.79

1.13

32.6

100.00

child’s BMI (kg/m2)

20.04 (3.92)

PFOA

3.23

1.30

3.28

0.43

5.87

100.00

child’s Body Fat (%)

24.94 (5.63)

PFNA

0.82

0.55

0.72

0.10 (LOQ)

4.14

98.80

mother’s BMI (kg/m2)

27.50 (5.60)

father’s BMI (kg/m2)

29.49 (4.50)

PFDA
PFHxS

0.26
6.06

0.13
8.03

0.26
3.67

0.10 (LOQ)
0.29

0.82
53.5

87.95
100.00

child’s height (inches)

55.53 (2.81)

PFOSA

0.75

0.57

0.61

0.10 (LOQ)

4.03

98.80

gender (0 = male; 1 = female)

36.14% female

race (0 = White; 1 = Other)
family History (0 = no; 1 = yes)

84.81% White

Table 3. Spearman’s Rank Correlation Coeﬃcients (rho)
among Diﬀerent PFCs in Blood Samples (N = 83)

diabetes

37.35% yes

heart disease

43.37% yes

cholesterol

51.81% yes

PFOS

0.95

1.00

high blood pressure

68.67% yes

PFOA

0.73d

0.71d

1.00

stroke

19.28% yes

PFNA

0.16

0.14

0.31c

1.00

asthma

30.12% yes

blood Pb (mg/dL
blood Hg (mg/dL)

total PFC PFOS PFOA

1.01 (0.44)
0.80 (1.39)
a

of various chronic illnesses (e.g., diabetes), blood Pb levels, and
blood Hg levels (see Table 1 for a partial listing of these variables).
Details regarding the methods for measuring these variables are
included in the SI as well as in a prior publication.38
Emotional Response to the DRL. Participants were administered the 16 item Brief Mood Introspection Scale (BMIS44). This
questionnaire includes a list of adjectives and requests participants to rate themselves on each item using a 4 point scale (1 =
definitely do not feel, 2 = do not feel, 3 = slightly feel, and 4 =
definitely feel). The BMIS was developed based on the assumption of a pair of orthogonal mood dimensions (pleasant-unpleasant and arousal-calm) with a second set of dimensions (positivetired and negative-relaxed) at a 45° rotation from the first set.45
Items were appropriately reverse scored and averaged to create
scores on these four mood dimensions.
Data Analysis. DRL Performance Data. Median IRTs were
calculated from 5 min bins across the 20 min task. Median IRTs
were positively skewed and therefore a natural log transformation
was used to further normalize the data. In addition, the money a
child earned at this task was used as an index of overall performance.
Based on nonresponses during the task, four children were classified
as refusing. One child never pressed the bar/pad and three children
stopped pressing after the first 5 min.
Analytic Models. The distribution of blood PFC levels was not
normally distributed and was therefore log-transformed before
analysis. As an alternative approach to illustrate the data, the
online Supporting Information file contains the results of nonparametric regressions on nontransformed data using the locally
weighted scatterplot smoothing method46 provided by SAS
PROC LOWESS. Furthermore, details regarding measurement
of all potential confound and results of bivariate analyses are
reported in the online SI. Using SAS PROC REG, DRL outcome
measures were regressed on PFC blood levels, controlling for all
potential confounds found to have a bivariate relationship to
outcome at p < 0.20. A similar approach to covariate selection has
been adopted in prior research37 and is considered a conservative

100.00

d

PFDA PFHxS PFOSA

PFDA
PFHxS

d

0.38
0.77d

0.32
0.63d

0.48d
0.37d

0.66d
0.07

1.00
0.16

1.00

PFOSA

0.35c

0.33c

0.18

0.15

0.12

0.25b

b

c

PFNA

c

1.00

d

p < 0.10. p < 0.05. p < 0.01. p < 0.001.

approach when controlling for potential confounds.47 As an
additional protection against results being a unique product of
our particular covariate selection method, the SI includes methods and results for a reanalysis of IRT data using a change-inestimate approach to covariate selection. As reported in the SI,
results were very similar using this alternative approach to
covariate selection. To avoid inflating our family wise error,
analyses of the four emotional dimensions assessed during the
DRL task were only conducted for total PFC concentrations.

’ RESULTS AND DISCUSSION
Sample Characteristics. Table 1 shows characteristics of the
children and their mothers and fathers in this sample. By design,
children in our sample were 9, 10, or 11 years old (M = 10.13).
Associations between PFC levels and baseline characteristics are
reported in SI Table S4. Table 2 reports the PFC levels for the
children in the current sample. As shown in Table 3, levels of
different PFCs in the blood for this population were intercorrelated. Because PFC levels are not normally distributed, Spearman’s rank correlation coefficients are reported in Table 3. As
shown in Table 3, levels of total PFC primarily reflect levels of
PFOS, PFOA, and PFHxS. Although not the focus of the present
study, serum lipids were measured in this cohort. The partial
correlations between PFCs and these levels (controlling for
gender, a family history of high cholesterol, and family income)
are reported in SI Table S5. Although PFDA was significantly
correlated with total cholesterol and LDL, these significant
associations might be a result of a conducting numerous correlations and a resulting Type I error.
Median IRTs. The median IRTs increased for each 5 min “bin”
across the 20 min DRL task (2.95, 5.51, 8.90, and 13.40 s,
respectively), suggesting learning acquisition. After covariate control
for potential confounds, we considered the association of blood
PFC levels with median IRT. As shown in Table 4, increasing total
8154

dx.doi.org/10.1021/es103712g |Environ. Sci. Technol. 2011, 45, 8151–8159

Environmental Science & Technology

ARTICLE

Table 4. Relationship of PFC Blood Levels to Median IRTs within Each Time Period of the DRL Task (Standardized β and 95%
Conﬁdence Intervals Are Shown; N = 79)a
DRL time period
PFC

b

05 min

c

1115 mind

610 min

1620 mine

total

0.11 [0.32, 0.10]

0.30** [0.50, 0.09]

0.30** [0.50, 0.09]

0.23* [0.45, 0.01]

PFOS

0.05 [0.26, 0.16]

0.18 [0.40, 0.04]

0.25* [0.46, 0.04]

0.20# [0.42, 0.02]

PFOA
PFNA

0.03 [0.24, 0.18]
0.07 [0.29, 0.14]

0.11 [0.34, 0.11]
0.24* [0.46, 0.02]

0.20# [0.41, 0.01]
0.15 [0.38, 0.07]

0.17 [0.39, 0.05]
0.05 [0.28, 0.18]
0.20# [0.43, 0.02]

PFDA

0.09 [0.30, 0.13]

0.24* [0.45, 0.02]

0.23* [0.45, 0.02]

PFHxS

0.13 [0.34, 0.09]

0.31** [0.53, 0.10]

0.20# [0.42, 0.02]

0.10 [0.32, 0.13]

PFOSA

0.13 [0.35, 0.08]

0.25* [0.46, 0.04]

0.17 [0.38, 0.05]

0.19# [0.42, 0.03]

a

#, p < 0.10; *, p < 0.05; **, p < 0.01; ***, p < 0.001. b Covariates included a family history of diabetes, gender, race, father and child BMI, and mother’s age.
Covariates included blood Pb, gender, body fat, parent’s education, family history of high blood pressure, and asthma. d Covariates included gender,
race, parent’s education, father’s age, family history of diabetes. e Covariates included race, father’s age, parent’s education, father’s BMI, and family
history of diabetes, heart disease, stroke, and high cholester.
c

PFCs were associated with significantly shorter IRTs at 510 min
and 1115 min (β s = 0.30, p-values < 0.01) as well as significantly shorter IRTs at 1620 min (β = 0.23, p < 0.05). Figure 1
shows the scatterplots for the association between total blood PFC
and IRTs. As can be seen in these figures, higher PFC blood levels
are associated with both shorter IRTs and smaller between-subject
variability. Associations with individual PFCs are also shown in
Table 4 and exhibit a similar pattern of associations; namely, the
weakest associations were found during the beginning of the task.
This pattern is not unusual for the DRL task (cf., ref 37) and reflects
the fact that differences in learning (and thereby performance) can
only emerge as exposure to the learning task progresses through time.
In order to illustrate the magnitude of signiﬁcant eﬀects using
the original units, Table 5 reports changes in median IRTs (in
seconds) and corresponding number of responses associated
with a 1 SD increase in the particular PFC. As shown in Table 5, a
1 SD increase in total PFC was associated with a decrease in
median IRT of 1.96, 3.65, and 8.27 s (for the 610, 1115, and
1620 min DRL periods, respectively) and a corresponding
increase in the number of responses to the task of 30.1, 23.4, and
50, during these same DRL periods. Expressed as a percent
change for those signiﬁcant eﬀects shown in Table 5, median IRT
decreased by 2934% for every 1 SD increase in the corresponding blood PFC. The magnitude of eﬀects for speciﬁc PFCs
(PFOS, PFNA, PFDA, PFHxS, and PFOSA) signiﬁcantly associated with reduced IRTs are also reported in Table 5.
Task Reward. As might be expected, poor performance (as
represented by short IRTs) resulted in significantly less money
being earned by those with increasing PFDA (β = 0.28, p <
0.05) and marginally less money for those with increasing blood
PFOS and PFOA (β = 0.19 and 0.21, respectively, p values
<0.10). In these analyses, covariates included father’s age, family
educational attainment, and a family history of diabetes.
Non-PFC Contaminants. Blood Pb and Hg were measured as
potential confounding contaminant exposures.37 Hg was not
associated with any outcome at p < 0.20 and therefore was not
included as a covariate in any model above. However, given the
significant positive association with blood PFCs and prior
findings of an association between prenatal MeHg and DRL
performance,37 we did repeat the analyses above with blood Hg
added as a covariate and, as expected, the results were unchanged.
Blood Pb was associated with IRTs during the 610 min period
and with the number of responses during the 1620 min time

period. However, when entered as covariates in the full model,
blood Pb was not significantly associated with these behavioral
outcomes (p values >0.10). This study did not have a sample
large enough to consider potential interactions between PFC and
either Pb or Hg exposure.
Task Emotion. Participants’ mood was assessed using the
BMIS following the DRL task. The analysis of the associations
between total PFC blood levels and the four mood dimensions
revealed no significant associations: pleasantunpleasant (β =
0.19, p = 0.10), negativerelaxed (β = 0.14, p > 0.25), arousalcalm
(β = 0.01, p > 0.25), and positivetired (β = 0.12, p > 0.25).
PFCs are ubiquitous environmental contaminants. In fact,
three PFCs that we measured (PFOS, PFOA, and PFHxS) were
found at detectable levels in all children in our sample. The present
study demonstrates that PFOS, PFNA, PFDA, PFHxS, PFOSA
levels in blood were all associated with signiﬁcantly poorer performance on a task requiring behavioral inhibition. The results demonstrate signiﬁcantly shorter IRTs and more frequent responses,
particularly in the middle of the task (between 5 and 15 min). In
addition, increasing blood PFDA was associated with children earning signiﬁcantly less money during this task. In short, increasing blood
levels for a number of diﬀerent PFCs appear to be associated with
greater impulsivity in children and this translated into poor performance on the DRL task. Although the pattern of associations did not
suggest an isolated eﬀect of a particular PFC, this question is diﬃcult
to address empirically in this sample because of the high intercorrelations among the six individual PFCs we measured at detectable levels.
In addition, although the concentration of some PFCs (PFOS and
PFOA) appear to have declined in the general U.S. population from
1999 to 2000 to 20032004,48 we still observed signiﬁcant associations at levels apparent in 20082009. It remains to be determined
whether the apparent decline in PFOS and PFOA will continue or
plateau and whether associations with neurobehavioral outcomes will
decline or continue. It is also unknown whether levels of PFCs other
than PFOS and PFOA are declining over time.
The association between PFCs and impulsivity (a deﬁning
feature of ADHD) revealed in the present study might explain the
recently observed associations between PFC levels and ADHD.15
Two studies have now documented a signiﬁcant increase in ADHD
risk associated with greater PFHxS 15,16 and our study demonstrated
a consistent association between PFHxS and impulsivity. However,
there remain a number of inconsistencies (e.g., a signiﬁcant association with ADHD/impulsivity was found for PFOS in our study and
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Figure 1. Relationship of total PFC concentrations in blood to IRTs during each DRL time period.

the NHANES sample, but not in the C8 Health Project) that are not
readily explained. Finally, if exposure to particular PFCs represents
an increasing risk for impulsivity and a corresponding diagnosis of
ADHD, then do PFC levels in the environment “track” ADHD
prevalence rates? The increasing prevalence of ADHD49 coupled
with a decline in PFC levels48 appears inconsistent with the idea that
these two variables might be causally connected. However, not all
PFCs have been declining (e.g., PFNA48). Futhermore, it is not
known whether our cross-sectional measurement of blood PFC
levels in 911 year old children serves as an indirect measure of
prenatal or perinatal PFC exposure. Therefore, if neurotoxic eﬀects
of PFCs occur speciﬁcally with prenatal or perinatal PFC exposure,
then a corresponding 911 year time-lag would be expected
between the environmental peak in PFC levels in the 1990s50 and
any corresponding peak in ADHD prevalence in children. Finally, a

potential link between temporal trends in environmental PFCs and
ADHD prevalence would depend on an understanding of the nature
of the PFC-ADHD relationship (e.g., linear vs nonlinear). For
example, the results of smoothed nonparametric regression (see SI
Figure 1S) suggest a potential nonlinear association with no IRTPFC association (ﬂat slope) at higher PFC levels. Therefore,
perhaps it is necessary for PFC levels to decline and reach an eﬀect
threshold before ADHD prevalence rates are aﬀected.
With respect to the generalizability of our ﬁndings, DRL tasks
vary in the particular response that is reinforced, the length of
the task, and the reinforcement schedule. For example, one DRL
task for children used points earned on a computer task and provided reinforcement of withholding responses for 6 s (a DRL-6
schedule51). In another study, the DRL apparatus included a
operant panel made to look like a clown’s face with marbles and
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Table 5. Magnitude of Signiﬁcant Associations Reported in Table 4, Expressed As the Change in Median IRTs (in Seconds) and
Number of Responses During DRL Period Associated with Each 1 Standard Deviation (SD) Increase in Blood PFC
1 SD increase in blood PFC
associated decrease from

associated increase from median

median IRT (in sec) [95% conﬁdence interval]

number of responses [95% conﬁdence interval]

610 min
1115 min

5.51a1.96 [0.722.88]
8.90  3.65 [1.315.18]

54.4b þ 30.1 [8.259.7]
33.7 þ 23.4 [5.846.9]

1620 min

13.40  8.27 [5.819.85]

22.4 þ 50 [17.162.1]

8.90  2.73 [0.584.33]

33.7 þ 14.9 [2.431.9]

5.51  1.88 [0.142.45]

54.4 þ 28.2 [1.543.6]

PFC DRL period
total PFC (SD = 14.00 ng/mL)

PFOS (SD = 6.09 ng/mL)
1115 min
PFNA (SD = 0.56 ng/mL)
610 min
PFDA (SD = 0.13 ng/mL)
610 min

5.511.62 [0.142.69]

54.4 þ 22.7 [1.552.0]

1115 min

8.903.01 [0.38  4.82]

33.7 þ 17.2 [1.539.8]

5.511.79 [0.612.69]

54.4 þ 26.2 [6.852.0]

5.511.71 [0.262.75]

54.4 þ 24.5 [2.754.3]

PFHxS (SD = 8.03 ng/mL)
610 min
PFOSA (SD = 0.57 ng/mL)
610 min
a

These represent the median IRT within the particular DRL period. b These represent the median number of responses given the length of the DRL
period (5 min) and the median IRT.

money used to reward pushing the clown’s nose every 20 s.37 The
task used in the present study represents a relatively brief (20 min)
assessment of DRL-20 learning. Although most children did not
consistently respond every 20 s (i.e., learn the schedule), the
increase in IRTs over time demonstrates learning. More importantly, the signiﬁcant associations emerged relatively quickly (after 5
min; cf., ref 37). Therefore, it is unlikely that the current associations
would diﬀer as a function of the particular response, reward
employed, or task length. It is possible that diﬀerent DRL schedules
are more (or less) sensitive to toxicant exposures however we have
no data with which to address this possibility.
There is a remarkable similarity between the PFC-DRL
associations in the present study and prior ﬁndings of associations between DRL performance and prenatal exposure to other
toxicants, namely polychlorinated biphenyls (PCBs) and Hg.37
There are two likely explanations for this similarity across studies.
Perhaps the current associations with PFCs emerged due to
underlying (and unmeasured) associations with prenatal exposure to PCBs and Hg or, alternatively, those prior associations of
PCBs and Hg with DRL performance may have emerged due to
underlying (and unmeasured) associations with postnatal PFC
exposure (unfortunately, we were unable to measure PCBs due
to a lack of suﬃcient blood for this analysis). As partial support
for this idea, blood PFC and Hg levels were signiﬁcantly
correlated in the present sample. PFC and Hg are likely
correlated due to a common food source for these toxicants,
namely ﬁsh.52 In contrast to prior ﬁndings for prenatal Hg
exposure,37 blood Hg for the present cohort was not found to
be signiﬁcantly associated with DRL performance. Alternatively,
some environmental toxicants may exert eﬀects on executive

control and response inhibition via multiple and separate pathways, all being sensitive to the ﬁnal outcome as measured by the
DRL task. Additional study is clearly needed to gain an understanding of the mechanism by which blood PFC levels might
aﬀect impulsivity, if such a causal pathway exists.
There are notable limitations with the present study. Foremost, we employed a cross-sectional study design making it
diﬃcult to establish causality. For example, it is possible that
children’s impulsive behavior produced behaviors that increased
exposure to PFCs. Similarly, although we controlled for many
potential confounds, other variables (e.g., maternal and paternal
impulsivity) should be considered in future studies of PFC
exposure eﬀects. The rationale would be that greater maternal
and paternal impulsivity might be associated with greater impulsivity in their child as well as associated with greater PFC
exposure through consumer choices and diﬀerential exposure to
PFCs. In addition, other toxicants (e.g., PCBs) might be confounds however we did not have a suﬃcient volume of blood to
measure additional toxicant exposures. As a second limitation,
our sample was a subset drawn from a larger study of volunteers.
In addition, the sample used in the present analyses did not
include all children that volunteered, resulting in disproportionately more males. However, gender was included as a covariate
when necessary and other potential covariates we measured were
not found to diﬀer between our full sample and the subset drawn
for the present study. Finally, our DRL task was administered to
911 year old children during their second hour of testing. As
such, the 20 min we allowed for this task was not suﬃciently long
to enable all children to achieve learning acquisition. Nevertheless, IRTs did increase during the task suggesting that, on
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average, children were beginning to learn the reinforcement
schedule albeit at diﬀering rates across diﬀering blood PFC levels.

’ CONCLUSIONS
The present study investigates blood levels of various PFCs in
children and associations with behavioral inhibition. The results
demonstrated signiﬁcant associations between blood levels for
multiple PFCs and behavioral inhibition deﬁcits in children as
measured using the DRL task. As a result, increasing blood PFC
levels were associated with earning signiﬁcantly less money
during this task. These results are intriguing and suggest a need
for further investigation and replication with a larger sample of
children.
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’ NOTE ADDED AFTER ASAP PUBLICATION
There were errors in Table 4 in the version published ASAP
on June 17, 2011. The corrected version was published on
June 29, 2011.
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